Intervention Clinic Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.62 M
as on 28-12-2024
- Revenue -34.90%
(FY 2017)
- Profit -4.92%
(FY 2017)
- Ebitda 151.73%
(FY 2017)
- Net Worth -738.99%
(FY 2017)
- Total Assets -10.99%
(FY 2017)
About Intervention Clinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.62 M.
Sunil Waghmare and Pratibha Waghmare serve as directors at the Company.
- CIN/LLPIN
U85110MH2007PTC172626
- Company No.
172626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2007
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Intervention Clinic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Waghmare  | Director | 26-Jul-2007 | Current |
| Pratibha Waghmare | Director | 26-Jul-2007 | Current |
Financial Performance of Intervention Clinic.
Intervention Clinic Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 34.9% decrease. The company also saw a slight decrease in profitability, with a 4.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 738.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intervention Clinic?
In 2017, Intervention Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Om Sai Super Speciality Hospitals Private LimitedActive 23 years 4 daysSunil Waghmare and Pratibha Waghmare are mutual person
- Sulochana Nursing Home Private LimitedActive 19 years 11 months
Sunil Waghmare and Pratibha Waghmare are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citicorp Finance (India) Limited Creation Date: 20 Oct 2007 | ₹0.85 M | Open |
Citicorp Finance (India) Limited Creation Date: 20 Oct 2007 | ₹0.85 M | Open |
Citicorp Finance (India) Limited Creation Date: 20 Sep 2007 | ₹1.92 M | Open |
How Many Employees Work at Intervention Clinic?
Unlock and access historical data on people associated with Intervention Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intervention Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intervention Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
